Opening Ceremony

What’s new in diagnosis of myocardial infarction

5th Universal definition of myocardial infarction
นพ. ณัฐวุฒิ วงษ์ประภารัตน์

AI-assisted ACS care
นพ. ธีรภัทร นันท์ศุภวัฒน์

MINOCA: When the Angiogram Is Normal-What Comes Next? 
พญ. ธนัญญา บุณยศิรินันท์

Hs-Troponin I/T Ratio in Differentiating Type 1 vs Type 2 MI: Old Dogs, New Tricks
นพ. กฤษฎา มีมุข

Pitfalls in diagnosing MI: Learn from the mistakes!
นพ. ศรัณย์ ควรประเสริฐ

Q and A
Moderator นพ. อภิชาต สุคนธสรรพ์

Value-driven pharmacotherapy post-MI

Beta-Blocker Debate: Post-MI Patients Without HF
Choice of antiplatelet therapy, final verdict?
Early Lipid-Lowering Intensification Post MI: Worth It?   
Q and A
Moderator

Value-driven care after PCI

Revascularization strategy of non-culprit lesion after STEMI – final answer? 
Intravascular imaging in complex PCI – neutralize by operator experience?
How soon can we drop aspirin after ACS?    
Q and A

ACC 2025 vs ESC 2025: Myocarditis and Pericarditis

What are the essential agreements and differences?
What are the obstacles to implementing in practice?
Applying guidelines to real case   
Q and A

Value-driven care beyond medications

Dietary guidance: AHA 2026
Cardiac rehabilitation: Update ESC 2026
Applying guidelines to real case

Value-driven care on valvular heart disease

ACC 2025 Expert consensus on Tricuspid Regurgitation
Transcatheter Tricuspid Valve Annuloplasty: 
A Note of Caution 
Early intervention in asymptomatic severe AS, 
any value? 
Q and A

Update ESC guideline 2026: CVD and CKD

Top 10 messages from the guideline
What are the obstacles to implementing in practice?
Update trials beyond guidelines 
(fish oil, FISH trial, PISCES trial)   
Q and A